GINKGO BIOWORKS HOLDINGS, INC.
Cash Flow Statement
| Line Item | Jun 2026 | Mar 2026 | Sep 2025 | Jun 2025 | Mar 2025 | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-46.7M | $-82.6M | $-80.8M | $-60.3M | $-91.0M | $-56.4M | $-217.2M | $-165.9M |
| Depreciation & Amortization | — | $12.8M | — | — | $14.8M | — | — | $12.9M |
| Depreciation | — | — | — | — | — | — | — | — |
| Amortization | $4.1M | $4.2M | $4.6M | $4.2M | $4.2M | $4.9M | $4.9M | $3.4M |
| Stock-Based Compensation | — | $15.9M | — | — | $17.4M | — | — | $40.8M |
| Net Cash from Operating Activities | $-44.3M | $-46.7M | $-31.6M | $-40.3M | $-51.5M | $-103.5M | $-84.4M | $-89.3M |
| Investing Activities | ||||||||
| Capital Expenditures | $2.6M | $1.9M | $0 | $38.0K | $7.6M | $15.1M | $27.0M | $6.7M |
| Business Acquisitions | — | — | — | — | $0 | — | — | $5.4M |
| Net Cash from Investing Activities | — | $23.1M | — | — | $-198.7M | — | — | $-12.1M |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | — | $-19.0K | — | — | $-207.0K | — | — | $-845.0K |
| Net Change in Cash | — | $-23.7M | — | — | $-250.3M | — | — | $-102.4M |
| Free Cash Flow | $-46.9M | $-48.6M | $-31.6M | $-40.3M | $-59.1M | $-118.6M | $-111.4M | $-96.0M |